174 related articles for article (PubMed ID: 19561778)
1. Continuous subcutaneous insulin infusion versus multiple daily injections.
Karagianni P; Sampanis Ch; Katsoulis Ch; Miserlis G; Polyzos S; Zografou I; Stergiopoulos S; Douloumbakas I; Zamboulis Ch
Hippokratia; 2009 Apr; 13(2):93-6. PubMed ID: 19561778
[TBL] [Abstract][Full Text] [Related]
2. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
[TBL] [Abstract][Full Text] [Related]
4. Comparison between continuous subcutaneous insulin infusion and multiple insulin injection therapy in type 1 diabetes mellitus: 18-month follow-up.
Hissa MN; Hissa AS; Bruin VM; Fredrickson LP
Endocr Pract; 2002; 8(6):411-6. PubMed ID: 15251830
[TBL] [Abstract][Full Text] [Related]
5. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injection in Children with Type I Diabetes in Kuwait: Glycemic Control, Insulin Requirement, and BMI.
; Mousa M; Al-Mahdi M; Al-Sanaa H; ; Al-Kandari H
Oman Med J; 2015 Sep; 30(5):336-43. PubMed ID: 26421114
[TBL] [Abstract][Full Text] [Related]
7. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic control in young children with type 1 diabetes treated with continuous subcutaneous insulin infusion (insulin pump)].
Pańkowska E; Lipka M; Wysocka M; Szypowska A; Trippenbach-Dulska H; Czaplińska M; Kołodziejska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):11-5. PubMed ID: 12831632
[TBL] [Abstract][Full Text] [Related]
9. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
10. IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS.
Vigersky RA; Huang S; Cordero TL; Shin J; Lee SW; Chhabra H; Kaufman FR; Cohen O;
Endocr Pract; 2018 May; 24(5):446-452. PubMed ID: 29847166
[TBL] [Abstract][Full Text] [Related]
11. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
[TBL] [Abstract][Full Text] [Related]
12. Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study.
Lepore G; Dodesini AR; Nosari I; Trevisan R
Diabetes Nutr Metab; 2004 Apr; 17(2):84-9. PubMed ID: 15244099
[TBL] [Abstract][Full Text] [Related]
13. Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.
Grunberger G; Bhargava A; Ly T; Zisser H; Ilag LL; Malone J; Fan L; Zhang S; Johnson J
Diabetes Obes Metab; 2020 Mar; 22(3):434-441. PubMed ID: 31865633
[TBL] [Abstract][Full Text] [Related]
14. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning.
Cyganek K; Hebda-Szydlo A; Katra B; Skupien J; Klupa T; Janas I; Kaim I; Sieradzki J; Reron A; Malecki MT
Diabetes Technol Ther; 2010 Jan; 12(1):41-7. PubMed ID: 20082584
[TBL] [Abstract][Full Text] [Related]
15. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
[TBL] [Abstract][Full Text] [Related]
16. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Glycaemic Control, Glucose Variability and Hypoglycaemia on Long-Term Continuous Subcutaneous Infusion vs. Multiple Daily Injections: Observational Study in Pregnancies With Pre-Existing Type 1 Diabetes.
Jotic A; Milicic T; Lalic K; Lukic L; Macesic M; Stanarcic Gajovic J; Stoiljkovic M; Gojnic Dugalic M; Jeremic V; Lalic NM
Diabetes Ther; 2020 Apr; 11(4):845-858. PubMed ID: 32060738
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.
Jeitler K; Horvath K; Berghold A; Gratzer TW; Neeser K; Pieber TR; Siebenhofer A
Diabetologia; 2008 Jun; 51(6):941-51. PubMed ID: 18351320
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.
Raskin P; Bode BW; Marks JB; Hirsch IB; Weinstein RL; McGill JB; Peterson GE; Mudaliar SR; Reinhardt RR
Diabetes Care; 2003 Sep; 26(9):2598-603. PubMed ID: 12941725
[TBL] [Abstract][Full Text] [Related]
20. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
Simon B; Treat V; Marco C; Rosenberg D; Joseph J; Hipszer B; Li Y; Chervoneva I; Padron-Massara L; Jabbour S
Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
